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Abstract
Taurine is an important osmolyte involved in cell volume regulation. During regulatory volume decrease it is released via a
volume-sensitive organic osmolyte/anion channel. Several molecules have been suggested as candidates for osmolyte release.
In this study, we chose three of these, namely ClC-2, ClC-3 and ICln, because of their expression in rat astrocytes, a cell type
which is known to release taurine under hypotonic stress, and their activation by hypotonic shock. As all three candidates
were also suggested to be chloride channels, we investigated their permeability for both chloride and taurine under isotonic
and hypotonic conditions using the Xenopus laevis oocyte expression system. We found a volume-sensitive increase of
chloride permeability in ClC-2-expressing oocytes only. Yet, the taurine permeability was significantly increased under
hypotonic conditions in oocytes expressing any of the tested candidates. Further experiments confirmed that the detected
taurine efflux does not represent unspecific leakage. These results suggest that ClC-2, ClC-3 and ICln either participate in
taurine transport themselves or upregulate an endogenous oocyte osmolyte channel. In either case, the taurine efflux of
oocytes not being accompanied by an increased chloride flux suggests that taurine and chloride can be released via two
separate pathways. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In many cell types, swelling stimulates the release
of inorganic and organic solutes, which results in a
regulatory volume decrease (RVD). Taurine is one of
the major osmolytes in mammalian cells and is also
released during RVD. Release of taurine has been
studied, among others, in glial cells [1,2], erythro-
cytes from di¡erent species [3], HeLa cells [4,5],
9HTEo human tracheal cells [6], and endothelial cells
[7].
The mechanism of taurine release shares a number
of characteristics with swelling-induced anion chan-
nels. Both, the release of chloride and the release of
taurine follow the same time course and both e¥ux
pathways can be inhibited by anion channel blockers
like NPPB, DIDS, tamoxifen and ni£umic acid [1,2].
In whole cell patch clamp experiments, a signi¢cant
permeability of swelling-induced anion channels for
taurine, aspartate and glutamate could be demon-
0005-2736 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 0 0 ) 0 0 2 0 9 - 1
* Corresponding author. Fax: +49-7071-293073;
E-mail : stefan.broeer@uni-tuebingen.de
BBAMEM 77871 24-7-00
Biochimica et Biophysica Acta 1467 (2000) 91^100
www.elsevier.com/locate/bba
strated [8]. In contrast, in other cell types, swelling-
induced taurine release and swelling-induced chloride
channels appear to have di¡erent pharmacological
pro¢les [5,9]. Taurine release has been intensively in-
vestigated in cultured astrocytes [1,10]. In most mam-
malian cells, regulatory volume decrease is mainly
achieved by release of K and Cl3. Yet, in the brain,
organic osmolytes are especially important in volume
regulation as they do not interfere with the K-ho-
meostasis of the brain, which is crucial for neuro-
transmission. Volume regulation by releasing organic
osmolytes is, therefore, a mechanism which might be
particularly important for the function of astrocytes.
A number of molecular candidates have been sug-
gested to be involved in regulatory volume decrease
(RVD) by release of anions or osmolytes: e.g. the
chloride channel family members ClC-2 [11] and
ClC-3 [12], the ICln protein [13], the anion exchanger
Band 3 (AE-1) [14], the mitochondrial voltage-depen-
dent anion channel (VDAC) [15] and the small mem-
brane protein phospholemman [16]. From these pro-
teins, only AE1 has been investigated in respect to
taurine permeation. By expression in X. laevis oo-
cytes, it could be demonstrated that AE-1 from
mouse was not permeable for taurine under hypo-
osmotic conditions, whereas the orthologous protein
from trout acted as a taurine release pathway under
these conditions [14]. The chloride channels ClC-2
and ClC-3 have been described as volume-sensitive
chloride channels. When expressed in Xenopus oo-
cytes, rat ClC-2 showed an increased Cl3 conduc-
tance under hypo-osmotic conditions [11]. ClC-3 ¢rst
been cloned from rat brain [17] was subsequently
cloned from guinea pig heart muscle and shown to
act as a volume-sensitive chloride channel when over-
expressed in transfected 3T3 cells [12]. Neither ClC-2
nor ClC-3 have been investigated in respect to their
permeability for osmolytes. Additionally ClC-3
might form heteromultimers with other channels of
the ClC-family, as it was found for ClC-1 and ClC-2
[18].
Expression of the ICln protein in Xenopus oocytes
was found to induce outwardly rectifying chloride
currents which are similar to the currents elicited in
cultured cells under hypo-osmotic conditions [19].
However, its precise structure and function remains
controversial. On the one hand, the ICln protein has
been proposed to form a chloride channel itself [13].
Other groups, however, have allocated ICln protein to
the cytosol, where it might be associated with actin.
This suggests a regulatory role rather than a channel
function of the ICln protein [19]. A further model
proposes ICln as a mediator between a cytoskeletal
volume-sensor and the volume-regulated ClC-3 [20].
Similar to ICln, the precise cellular location of the
voltage-dependent anion channel (VDAC) has not
been clari¢ed as well. VDAC is established as a chan-
nel of the outer mitochondrial membrane, however
its allocation to the plasma membrane remains con-
troversial [21].
In this study, we have investigated the expression
of ClC-2, ClC-3 and ICln in cultured astrocytes which
show signi¢cant release of taurine under hypo-os-
motic conditions. Furthermore, we expressed all
three candidates in the X. laevis oocytes expression
system in order to investigate their permeation prop-
erties.
2. Materials and methods
2.1. Materials
L-[1,2-3H]Taurine (703 Gbq/mmol), [3H]inulin
(29.6 GBq/mmol) and L-[U-14C]lactate (5.66 Gbq/
mmol), 3H2O (185 MBq/ml) and Na36Cl (18.6
GBq/mol) were purchased from Amersham Buchler
(Braunschweig, Germany). The RNA cap structure
analog 7 mG(5P)ppp(5P)G was purchased from New
England Biolabs (Schwalbach, Germany). Restric-
tion enzymes, nucleotides and polymerases were
from Life Technologies, (Eggenstein, Germany) or
Boehringer-Mannheim (Germany), the Taq-polymer-
ase from Life Technologies (Eggenstein, Germany),
the Pfu-polymerase was from Promega (Mannheim,
Germany). The PCR-Script AMP cloning kit was
purchased from Stratagene (Amsterdam, Nether-
lands). Collagenase (EC 3.4.24.3; 0.3 U/mg from
Clostridium histolyticum) was purchased from Boehr-
inger-Mannheim (Germany); lots were tested for
their suitability for oocyte expression. Streptolysin
S was obtained from Sigma (Deisenhofen, Germany).
All other chemicals were of analytical grade and sup-
plied by Merck (Darmstadt, Germany), Roth (Karls-
ruhe, Germany) or Boehringer-Mannheim (Ger-
many).
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2.2. Methods
2.2.1. Cell culture
Astroglia-rich primary cultures were prepared
from newborn rat brains as described before [22].
Brie£y, total brains were passed successively through
two nylon nets of 211 and 135 Wm mesh width. The
suspended cells of complete o¡spring (10^15 animals)
were collected by centrifugation and resuspended in
20 ml DMEM/10% FCS. After determination of the
cell number, cells were diluted in DMEM/10% FCS
to a ¢nal density of 200 000 cells/ml. Aliquots were
dispensed in cell culture dishes of appropriate size
and incubated in a cell incubator at 37‡C, 90% air,
10% CO2 for 14^21 days. The medium was renewed
every week. Neuron-rich primary cultures were de-
rived from embryonal rat brains (E16) as described
before [22]. Brie£y, embryo brains were passed suc-
cessively through two nylon nets of 135 and 20 Wm
mesh width. One million cells were seeded onto poly-
D-lysine coated 35 mm dishes. After 3 days in cul-
ture, cells were treated for 24 h with cytosine arabi-
noside at a ¢nal concentration of 0.5 WM to kill
dividing cells. Subsequently, cells were incubated in
glia-conditioned neuron culture medium. The cul-
tures were used at a culture age of 5^7 days. These
cultures contain some astroglial cells, but no oligo-
dendroglial or ependymal cells as determined by cell-
speci¢c markers.
2.2.2. RT-PCR
Total RNA was isolated from astroglia-rich and
neuron-rich primary culture and from fetal (E16)
and adult rat brain by the acid guanidinium thiocya-
nate^phenol^chloroform extraction method. mRNA
was isolated from total RNA using oligo-dT cellu-
lose. mRNA was reverse transcribed with Superscript
II reverse transcriptase using an oligo-dT primer.
For the detection of ClC-2, ClC-3 and ICln mRNA
in rat brain the following primers were used: oligo-
nucleotides ICLNs 5P-AGCTTCCTCAAAAGCTT-
CCC-3P and ICLNa 5P-GGTGGGGTACTCCAGT-
GAGA-3P, corresponding to bases 45^64 and to
bases 221^202, respectively, of the rat ICln cDNA
[19] (accession no. L26450) were used to amplify a
177-bp product. The corresponding sequences are
98% identical in rat and canine ICln cDNA [13].
ClC-3 primers were speci¢c to ClC-3 sequence as to
avoid coampli¢cation of other members of the ClC-
family. Oligonucleotides ClC3s 5P-CAGCCATTAC-
TGCTGTGATAGCC-3P and ClC3a 5P-GCTCCAC-
AGCAATCCCCTCAATC-3P corresponding to
bases 1628^1650 and to bases 1963^1941, respec-
tively, of the ClC-3 cDNA sequence [17] (accession
no. D17521) were used to amplify a 336-bp product.
The ClC-2 primers were chosen to distinguish be-
tween the cDNA sequences of two splice variants
ClC-2L and ClC-2S which contain or lack the se-
quence encoded by exon 20 [23] (accession no.
AF005720). Oligonucleotide ClC2s 5P-CACAGAG-
GACTCAGGCTTCC-3P corresponded to bases
2220^2239 ClC-2 cDNA sequence (encoded by
exon 19) and oligonucleotide ClC2a 5P-TCATCTTG-
CCTTCCAGGTCT-3P corresponded to bases 2494^
2475 of the ClC-2 cDNA (encoded by exon 21). The
length of the product depends on the presence (275
bp) or absence (215 bp) of the cDNA sequence of
exon 20. For this analytical PCR cDNA was ampli-
¢ed in a 30-cycle PCR reaction (60 s at 94‡C^60 s at
55‡C^30 s at 72‡C) using Taq-polymerase. The iden-
tity of the PCR products was veri¢ed by restriction
analysis. The digestion of the 177-bp product of rat
ICln with PstI yielded fragments of 125 and 52 bp,
except for the control, which was ampli¢ed from a
plasmid containing the canine sequence. The ClC-3
speci¢c PCR product of 336 bp was cut by PvuI into
a 305- and a 31-bp fragment. Digestion of the ClC-2
speci¢c products with KpnI yielded in any case a 105-
bp fragment and additionally a 110- or a 170-bp
fragment resulting from the short (215 bp) or the
long product (275 bp), respectively.
2.2.3. Cloning of ClC-3
Rat ClC-3 cDNA was cloned by high ¢delity RT-
PCR. For this, mRNA isolated from astroglia-rich
primary cultures, was reverse transcribed. For PCR,
two primers were constructed which £anked the
coding sequence of ClC-3. Oligonucleotide ClC3bs
5P-CGGGATCCTGCAAGGAACTCATTATACA-
ATG-3P corresponded to bases 479^500 of the ClC-3
cDNA sequence [17] fused to an BamHI restriction
site. Oligonucleotide ClC3xa 5P-GCTCTAGACCT-
CATCTACAGGACTCAGTTG-3P corresponded to
bases 2796^2775 fused to an XbaI site. The cDNA
was ampli¢ed in a 35-cycle PCR reaction (45 s at
94‡C^45 s at 50‡C^420 s at 72‡C) using Pfu-polymer-
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ase. The ampli¢ed PCR product of 2318 bp length
was puri¢ed by agarose gel electrophoresis and li-
gated into the SrfI site of pPCRscript. The BamHI
and XbaI fragment of ClC-3 was then subcloned into
the BamHI/XbaI digested oocyte expression vector
pGEM-He-Juel [24]. The ClC-3 cDNA was se-
quenced using the dye termination cycle method to
exclude any substitutions possibly caused by PCR
ampli¢cation. The sequence was found to be identi-
cal to the sequence published by Kawasaki et al. [17]
except for one polymorphism found in two indepen-
dent PCR products. This substitution of G by A at
position 2171 causes an amino acid exchange from
valine to isoleucine at position 716.
A plasmid containing rat ClC-2 was kindly sup-
plied by Prof. T. Jentsch (ZMNH, University of
Hamburg, Germany). It consists of the XhoI^EcoRI
fragment of ClC-2 cDNA cloned into the vector
pBluescriptSK containing the 5P-UTR of the Torpedo
ClC-0 cDNA. The HindIII^XhoI fragment of canine
ICln cDNA [13] was excised from the vector
pcDNA3.1 and cloned into the same sites of pBlue-
scriptKS.
2.2.4. cRNA expression in X. laevis oocytes
For in vitro transcription, plasmid DNA was lin-
earized with SalI (ClC-3), BamHI (ClC-2) or XhoI
(ICln) and transcribed in vitro with T7-RNA poly-
merase in the presence of a cap analog. The protocol
supplied with the polymerase was followed with the
exception that all nucleotides and the cap analog
were used at two-fold concentrations (1 mM) to in-
crease the yield of complementary RNA (cRNA).
Template plasmids were removed by digestion with
RNase-free DNase I. The cRNA was puri¢ed by
phenol/chloroform extraction followed by precipita-
tion with 1/2 vols. of 7.5 M ammonium acetate and
2 vols. of ethanol to remove unincorporated nucleo-
tides. After determination of the amount of cRNA
by measuring absorption at 260 nm, integrity of the
transcript was veri¢ed by denaturing agarose gel
electrophoresis.
X. laevis females were obtained from Knysna
(South Africa). Oocytes (stages V and VI) were
isolated by collagenase treatment of ovary lobes as
described before [25] and allowed to recover over-
night. They were microinjected with 25^50 nl
cRNA in water at a concentration of 0.3^0.6 Wg/Wl
using a nanoliter injector (WPI, Berlin, Ger-
many).
2.2.5. Determination of the solute-accessible oocyte
volume
The solute-accessible volume of oocytes was deter-
mined by silicon-oil centrifugation. Oocytes were
preincubated for 20 min in isotonic ND96 bu¡er
containing 370 kBq 3H2O/ml. Then the bu¡er was
diluted to 50% osmolarity with water containing
the same amount of 3H2O. After incubation of 0^
45 min single oocytes were placed on top of a layer
of silicon oil (PN200, Roth, Karslruhe, Germany) in
a 400 Wl microcentrifuge tube. The tube was imme-
diately centrifuged in a Beckmann Microfuge E for
30 s. For the determination of the cell-associated
radioactivity, the oocyte-containing tip was cut o¡
with a hot scalpel. The tip was placed upside down
in a microcentrifuge tube and the content was ex-
truded by centrifugation. The pellet was homoge-
nized by addition of 750 Wl water and vigorous vor-
texing. The radioactivity was determined by liquid
scintillation counting.
2.2.6. E¥ux experiments
Oocytes were injected with 50 nl of HEPES-bu¡-
ered [3H]taurine (24 kBq/Wl, 100 mM), Na36Cl
(0.925 kBq/Wl, 115 mM), [3H]inulin (37 kBq/Wl, 1.3
mM) or [14C]lactate (3.7 kBq/Wl, 100 mM). Oocytes
were allowed to recover for 5^30 min, before the
e¥ux experiment was conducted. Five oocytes were
washed two times with 3 ml ND96 bu¡er (96 mM
NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2 and
5 mM HEPES, pH 7.4, 210 mosM) and subsequently
suspended in 1 ml ND96 (isotonic conditions) or
ND48 (hypotonic conditions, 105 mosM, NaCl re-
duced to 48 mM). In the case of 36chloride e¥ux
experiments, extracellular sodium chloride was re-
placed by sodium gluconate. In the experiments in
which e¥ux was elicited by streptolysin S (5000
U/ml) the volume of transport bu¡er was reduced
to 200 Wl per group of ¢ve oocytes. Over a period
of 45 min, aliquot samples of 75 or 15 Wl (in the case
of streptolysin S) were taken from the supernatant
and their radioactivity was determined by liquid scin-
tillation counting. To calculate the e¥ux curve, the
amount of radioactivity in the supernatant at each
time point was integrated over time. The released
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radioactivity represents the summarized e¥ux activ-
ity of ¢ve oocytes per experiment. Therefore, no
standard deviations are given. For the ¢gures the
released radioactivity was divided by the number of
oocytes in the test tube. As no di¡erence in e¥ux
characteristics was found between non-injected and
H2O-injected oocytes, the former were used as con-
trols in the e¥ux experiments. The e¥ux measure-
ments were performed 3^6 days after cRNA-injec-
tion. Experiments performed with the same batch,
but on di¡erent days, always resulted in qualitatively
comparable data. All experiments were repeated with
two to three batches of oocytes. Although e¥ux rates
varied between batches, qualitatively comparable
data were obtained. The ¢gures show single represen-
tative experiments.
2.2.7. Electrophysiology
Two-electrode voltage-clamp recordings were per-
formed 3^6 days after injection at room temperature
using a Geneclamp 500 ampli¢er (Axon Instru-
ments). From a holding potential of 340 mV voltage
ramps from 3150 to +50 mV were performed. The
data were ¢ltered at 100 Hz and recorded with Mac-
Lab digital to analog converter and software for
data acquisition and analysis (AD Instruments, Cas-
tle Hill, Australia). ND96 bu¡er (as described above)
was used as control solution (superfusate). For the
isotonic and hypotonic ND48 solutions, NaCl was
reduced to 48 mM and osmolarity was adjusted by
adding 96 mM glucose for the isotonic control solu-
tion. The £ow rate of the superfusion was 20 ml/min
and a complete exchange of the bath solution was
reached within 10 s. The currents given are steady-
state currents for the control conditions and maximal
stimulation under hypotonic solution after 30 min.
Data are provided as means þ S.E., n represents
the number of oocytes investigated. Therefore,
throughout the paper, we show experimental data
obtained on the same day for each speci¢c set of
experiments. All experiments were repeated with at
least two to three batches of oocytes; in all repeti-
tions qualitatively similar data were obtained.
3. Results
3.1. Expression of osmolyte channel candidates in rat
brain
Cultured astrocytes show a signi¢cant release of
chloride and taurine under hypo-osmotic conditions,
therefore we investigated the mRNA expression of
three candidates potentially involved in the osmolyte
release in brain cells. The presence of ClC-2, ClC-3
or ICln mRNA in RNA or mRNA samples isolated
from fetal rat brain (E16), adult brain, neuron-rich
primary cultures and astroglia-rich primary cultures
was determined by RT-PCR. Plasmids containing the
full-length cDNA sequences of the three candidates
were used as positive controls (Fig. 1). The three
candidates were found to be expressed in fetal brain
(data not shown), adult brain as well as in cultured
neurons and astrocytes (Fig. 1). For ClC-2, at least
two splice variants, ClC-2L and ClC-2S, have been
described, which are characterized by the presence or
absence of exon 20 [23]. In whole brain and in as-
troglia-rich primary cultures, both splice variants,
ClC-2L and ClC-2S, were detectable. For neuron-
rich primary cultures, only the larger splice variant,
ClC-2L, was found (Fig. 1).
Fig. 1. Expression of ClC-2, ClC-3 and ICln mRNA in rat brain
detected by RT-PCR. The expected size of the ampli¢ed prod-
ucts is 275 bp for ClC-2L, 215 bp for ClC-2S, 336 bp for ClC-
3 and 177 bp for ICln. Control reactions were performed with
plasmid templates (lane 1). mRNA was isolated from adult rat
brain (lane 2) from neuron-rich primary culture (lane 3), or as-
troglia-rich primary culture (lane 4) and ClC-2, ClC-3 and ICln
were detected subsequently. As DNA-standard, a 100-bp ladder
was used (lane M).
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3.2. Volume changes of X. laevis oocytes
In order to study volume regulatory processes in
the Xenopus oocyte expression system, we ¢rst inves-
tigated the volume changes of oocytes induced by
hypo-osmolarity. X. laevis oocytes have a diameter
of about 1 mm corresponding to a calculated spher-
ical volume of 525 nl. As the oocytes contain a high
percentage of lipid-rich egg yolk, the solute accessible
volume is likely to be less than the total volume. We
determined the solute accessible volume of the oo-
cytes by equilibration with 3H2O-containing bu¡er.
The mean solute-accessible volume of the oocytes
was 364 þ 21 nl (S.E.M., n = 3), which represents
about 70% of the calculated volume of 525 nl.
Upon reduction of the osmolarity to 50%, the oo-
cytes swelled to a solute accessible volume of
484 þ 15 nl (S.E.M.) within 1 min. A plateau with a
maximal solute accessible volume of 667 þ 27 nl
(S.E.M.) was reached after 25 min, which represents
an increase to 183% of the volume under isotonic
conditions (Fig. 2).
3.3. E¥ux experiments
We found oocytes to be a suitable expression sys-
tem for the investigation of taurine transport. Con-
trol oocytes were almost impermeable to taurine.
Even after preloading overnight only small amounts
of labeled taurine were taken up by the oocytes.
Therefore oocytes were preloaded by injection of
[3H]taurine. To determine whether this method is
suitable for e¥ux studies, we examined the e¥ux of
lactate through the well-characterized rat H/mono-
carboxylate cotransporter MCT1 [22]. About 55% of
injected lactate (5 nmol) was released by MCT1-ex-
pressing oocytes under isotonic conditions, the major
e¥ux occurring within the ¢rst 20 min. Control oo-
cytes released less than 3% after 1 h of incubation
(Fig. 3).
To ensure that the injected taurine was not de-
graded or irreversibly bound by oocyte components,
we studied the e¥ux of taurine through a pore of less
than 3 nm formed by the bacterial toxin streptolysin
S [26]. During an incubation of oocytes with strepto-
lysin S (5000 U/ml) for 45 min under isotonic con-
ditions about 60% of the injected taurine was re-
leased (Fig. 4), a similar fraction as the released
lactate in the experiment described above. On the
other hand, only 1% of injected inulin, which is too
large to pass through the pores, was released under
identical conditions.
3.4. Chloride channel activity
Both ClC-2 and ClC-3 have been described as vol-
Fig. 2. Swelling of oocytes under hypotonic conditions. The sol-
ute accessible volume of the oocytes was calculated from the
3H2O content of single oocytes. Oocytes were incubated in
ND96 containing 3H2O. After reduction of osmolarity by 50%
dilution with water (containing the same amount of 3H2O), oo-
cytes were removed from the bu¡er at di¡erent times of incuba-
tion and stripped of residual bu¡er by silicon oil centrifugation.
Values are means þ S.E.M.
Fig. 3. E¥ux of injected [14C]lactate from oocytes. Oocytes
were injected with [14C]lactate and were then incubated ND96
in groups of ¢ve. At the indicated times of incubation, samples
were taken from the supernatant and radioactivity was deter-
mined. b, Oocytes expressing the rat monocarboxylate trans-
porter 1 (MCT1); a, control oocytes.
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ume-regulated chloride channels [11,12]. ICln cRNA
was shown to induce chloride currents when ex-
pressed in oocytes under certain conditions. There-
fore, we ¢rst studied the chloride channel activity in
oocytes expressing these three candidates by electro-
physiological and Cl3 e¥ux experiments.
Following an expression period of 3^6 days, oo-
cytes were injected with Na36Cl. After a washing
step, the combined e¥ux of chloride of a group of
¢ve oocytes was monitored by removal of aliquots
from the isotonic or hypotonic bu¡er. Comparable
results were obtained from at least three di¡erent
batches of oocytes. Chloride e¥ux within 45 min
varied in control oocytes between 0.2 and 1 nmol
per oocyte under isotonic conditions and between
0.6 and 2.7 nmol under hypotonic conditions. In
ClC-3 or ICln-expressing oocytes, no signi¢cantly dif-
ferent e¥ux rates were observed. Under isotonic con-
ditions, the e¥ux was between 0.2 an 1 nmol which
increased under hypotonic conditions only to 0.8^2
nmol. However, in agreement with previously pub-
lished results, we detected signi¢cant release of 36Cl
in ClC-2-expressing oocytes, even under isotonic con-
ditions. In a representative experiment, we measured
a chloride e¥ux of about 4 nmol/45 min per oocyte
as compared to an e¥ux of less than 1 nmol/45 min
in control oocytes. Reduction of osmolarity to 50%
(210 to 105 mosM) increased the e¥ux after about 20
min signi¢cantly. After a 45-min incubation, the ef-
£ux was about three-fold (11 nmol/oocyte) increased
compared to the e¥ux under isotonic conditions
(Fig. 5). When compared to the course of swelling
(Fig. 2), it seemed that the opening of ClC-2 requires
a signi¢cant increase of oocyte volume to about
twice the original volume.
The ICln protein has also been proposed to act as a
regulator of ClC-3 [20]. However, coexpression of
ClC-3 and ICln cRNA did not lead to an increased
e¥ux of chloride, neither under isotonic nor under
hypotonic conditions when compared to oocytes ex-
pressing ClC-3 or ICln alone (Fig. 5). The coexpres-
sion of ClC-2 with ClC-3 similarly did not result in
any signi¢cant increase of 36Cl release when com-
pared to oocytes expressing ClC-2. These results
were con¢rmed by electrophysiological determina-
tion of chloride conductance.
ClC-3-, ICln- or ClC-3+ICln-expressing oocytes
showed conductances below 4 WS and were not sig-
Fig. 4. E¥ux of injected [3H]taurine from oocytes through
pores formed by streptolysin S. Oocytes were injected with
[3H]taurine and were then incubated in groups of ¢ve. At the
indicated times of incubation, samples were taken from the
supernatant and radioactivity was determined. The e¥ux of un-
treated control oocytes (a) was compared to the e¥ux of oo-
cytes treated with 5000 U/ml streptolysin S (R).
Fig. 5. E¥ux of chloride from oocytes expressing ClC-2, ICln,
ClC-3 and ClC-3+ICln. Oocytes expressing ClC-2, ICln, ClC-3 or
ClC-3+ICln (solid symbols in each ¢gure) or control oocytes
(open symbols) were injected with Na36Cl and were then incu-
bated in isotonic or hypotonic bu¡er in groups of ¢ve oocytes.
At the indicated times of incubation, samples were taken from
the isotonic (a, b) or hypotonic (E, F) incubation bu¡er and
radioactivity was determined.
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ni¢cantly di¡erent from control oocytes under iso-
tonic or hypotonic conditions as determined in sev-
eral batches of oocytes (Fig. 6). ClC-2-expressing
oocytes, in contrast, showed 8.47 þ 1.3 WS (n = 7)
conductance which increased within 20 min of hypo-
tonic incubation to 35.4 þ 3.5 WS (n = 7) (Fig. 6).
3.5. Osmolyte channel activity
To test whether any of the candidates were able to
mediate the e¥ux of taurine, we performed e¥ux
experiments with [3H]taurine-injected oocytes. Varia-
tions of taurine e¥ux rates were found between oo-
cyte batches. Minimum e¥ux rates of taurine under
hypotonic conditions were 170 pmol/45 min (per oo-
cyte) in cRNA-injected oocytes and 40 pmol/45 min
in the control. Whereas, in a di¡erent batch, maxi-
mum taurine e¥ux rates of 840 pmol/45 min and 315
pmol/45 min were measured in cRNA-injected and in
controls, respectively. However, there was always a
signi¢cant di¡erence between control oocytes and
cRNA-injected oocytes as well as between isotonic
and hypotonic conditions. In the representative ex-
periments depicted in Fig. 7, the basal taurine e¥ux
in control oocytes varied between 15 and 40 pmol
per oocyte within 45 min under isotonic conditions.
Under hypotonic conditions e¥ux varied between 94
and 315 pmol per oocyte within 45 min. Under iso-
tonic conditions the taurine e¥ux rate in oocytes
injected with cRNA coding for ClC-2, ClC-3 or
ICln were similar to the e¥ux of control oocytes,
varying between 18 and 166 pmol of taurine within
45 min per oocyte. However, under hypotonic con-
ditions, a signi¢cantly increased taurine e¥ux be-
tween 700 and 840 pmol per oocyte within 45 min
was observed for each of the expressed cRNAs (Fig.
7). The hypotonicity induced e¥ux of taurine fol-
lowed a similar time course as the release of chloride
by hypotonicity activated ClC-2, showing a lag phase
of about 10^20 min. After 45 min, about 20% of the
injected taurine was released from the oocytes.
In order to ¢nd out whether this taurine e¥ux
represents a cRNA-speci¢c or an endogenous re-
sponse, we performed the same experiment with
MCT1-expressing oocytes. Surprisingly, we also ob-
served a swelling-induced e¥ux of taurine of about
700 pmol/45 min per oocyte in the MCT1-expressing
Fig. 6. Current^voltage relation in ClC-2-, ICln-, ClC-3- and
ClC-3+ICln-expressing oocytes. Oocytes were injected with
cRNAs of ClC-2, ICln, ClC-3 or ClC-3+ICln. Voltage ramps
were performed between 3150 and +50 mV under isotonic (a)
and hypotonic conditions (b).
Fig. 7. E¥ux of taurine from oocytes expressing in ClC-2, ICln,
ClC-3 and ClC-3+ICln. Oocytes expressing ClC-2, ICln, ClC-3 or
ClC-3+ICln (solid symbols in each ¢gure) or control oocytes
(open symbols) were injected with [3H]taurine and were then in-
cubated in isotonic or hypotonic bu¡er in groups of ¢ve oo-
cytes. At the indicated times of incubation, samples were taken
from the isotonic (a, b) or hypotonic (E, F) incubation bu¡er
and radioactivity was determined.
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oocytes (data not shown). Control oocytes showed
an e¥ux of about 250 pmol/45 min under hypotonic
conditions (data not shown).
Overexpression of membrane proteins might have
caused unspeci¢c leakage of the substrate in these
experiments. Therefore, we examined the permeabil-
ity of non-injected and ClC-3-expressing oocytes for
[3H]inulin under isotonic and hypotonic conditions.
Only a marginal e¥ux of inulin was observed (less
than 0.5%), irrespective of the osmolarity of the bu¡-
er.
4. Discussion
Several channels have been discussed as pathways
of organic osmolyte e¥ux. In this study, we tested
two candidates of the ClC-family of chloride chan-
nels, ClC-2 and ClC-3, and the putative osmolyte
channel protein ICln for the e¥ux of chloride and
taurine. These proteins were chosen because they
are the most probable candidates for osmolyte chan-
nels and are all expressed in astrocytes, a cell type
which is known to release taurine during hypo-os-
motic stress [1].
Rat ClC-2 has been expressed in Xenopus oocytes
and is known to be volume-sensitive [11]. In our
study, we were able to demonstrate the volume-sen-
sitivity of ClC-2 by electrophysiological recordings
and £ux studies using the radioactive isotope 36Cl3.
An e¥ux of about 20 nmol Cl3/h was detected. This
would correspond to a current of about 0.5 WA. At
the resting potential of oocytes, which lies close to
340 mV, currents within a similar range were deter-
mined under voltage-clamp conditions.
Both ClC-3 and ICln have been reported to act as
chloride channels when expressed in oocytes [13,17].
However, subsequent experiments in other laborato-
ries failed to demonstrate chloride channel activity
with ClC-3. Even coexpression of ClC-3 with two
other members of the ClC-family, ClC-4 and ClC-
5, did not result in any change of the channel char-
acteristics of single ClC-5 [27]. Using an epitope-tag
construct, we were able to demonstrate a signi¢cant
expression of ClC-3 in the plasma membrane of oo-
cytes under our conditions (unpublished result). The
function of the ICln protein as an osmolyte channel is
a matter of debate. Expression cloning suggests that
ICln itself constitutes a chloride channel [13].
Although the protein was detected in the cytosol
under isotonic conditions, hypotonic shock results
in the association with the membrane fraction [28].
In contrast, it was shown that expression of ClC-6 in
X. laevis oocytes results in the induction of similar
currents as those reported for ICln and it was con-
cluded that the expression of these proteins might
upregulate endogenous oocytes channels [29]. How-
ever, the expression was very low and had to be
optimized by an increase of the incubation temper-
ature [29]. It has been further proposed that the ICln
protein might act as an activator of ClC-3 [20]. In
our experiments, however, coexpression of both pro-
teins did not result in the expression of signi¢cant
chloride £uxes. To study taurine release, we have
used collagenase-treated oocytes, which have a low
level of oocyte endogenous transporters and have
been successfully used in the expression of a broad
variety of transporters and channels (amino acid
transporters, monocarboxylate transporters, non-spe-
ci¢c anion transporters, sodium channels). In agree-
ment with this notion, we could not detect the oocyte
endogenous volume-regulated chloride channel,
which reportedly can only be detected in manually
defolliculated oocytes shortly after the manipulation,
but not in collagenase-treated oocytes [30,31]. In
these oocytes, we could not detect ICln-induced chlo-
ride currents, which might result from a failing asso-
ciation of the ICln protein to the plasma membrane
under hypotonic conditions or the enzmyatic remov-
al of the follicular cell layer. To our surprise, how-
ever, we detected signi¢cant volume-sensitive taurine
e¥ux in oocytes expressing ClC-2, ClC-3, ICln and
MCT1. This e¥ux was not caused by unspeci¢c leak-
age of the oocytes, since we could show that injected
labeled inulin was not released under these condi-
tions. Two alternative conclusions are compatible
to this observation: (1) all four proteins mediate
the e¥ux of taurine irrespective of any Cl3 channel
activity; and (2) overexpression of these heterologous
membrane proteins results in the upregulation of an
endogenous taurine e¥ux pathway in Xenopus oo-
cytes. Considering the unrelatedness of the four
transport molecules, the latter conclusion seems
more likely. The second conclusion is also supported
by an upregulation of taurine e¥ux by expression of
the membrane protein h4F2hc, which under physio-
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logical conditions mediates the plasma membrane
tra⁄cking of amino acid transporters [32].
It has been proposed by di¡erent groups [1,2,33]
that volume-sensitive osmolyte release is mediated by
non-speci¢c anion channels. However, taurine-specif-
ic pathways have been proposed as well [5,9,34]. The
experiments presented here, clearly show an induc-
tion of taurine release in oocytes which does not
coincide with a signi¢cant increase in chloride per-
meability. Thus the expression of ICln, ClC-2, ClC-3,
or MCT1 is likely to upregulate an oocyte endoge-
nous osmolyte channel with these properties.
Acknowledgements
We thank Angelika Bro«er for technical assistance,
especially for the oocyte preparation. This study was
supported by grants of the European Union (BMH4-
CT96-0602) and of the Deutsche Forschungs Ge-
meinschaft (DFG) (Br1318/2-2) to S.B.
References
[1] H. Pasantes-Morales, J. Moran, A. Schousboe, Glia 3 (1990)
427^432.
[2] P.S. Jackson, K. Strange, Am. J. Physiol. 265 (1993) C1489^
C1500.
[3] R. Motais, H. Guizquarn, F. Garcia-Romeu, Biochim. Bio-
phys. Acta 1075 (1991) 169^180.
[4] J. Kirk, K. Kirk, J. Biol. Chem. 296 (1994) 29389^29394.
[5] A. Stutzin, R. Torres, M. Oporto, P. Pacheo, A.L. Eguigu-
ren, L.P. Cid, F.V. Sepulveda, Am. J. Physiol. 277 (1999)
C392^C402.
[6] L.J. Galietta, S. Falzoni, F. Di Virgilio, G. Romero, O.
Zegerra-Moran, Am. J. Physiol. 273 (1997) C57^C66.
[7] V.G. Manolopoulos, T. Voets, P.E. Declerq, G. Droogmans,
B. Nilius, Am. J. Physiol. 273 (1997) C214^C222.
[8] U. Banderali, G. Roy, Am. J. Physiol. 263 (1992) C1200^
C1207.
[9] I.H. Lambert, E.K. Ho¡mann, J. Membr. Biol. 142 (1994)
289^298.
[10] H. Pasantes-Morales, R.A. Murray, R. Sanchez-Olea, J.
Moran, Am. J. Physiol. 266 (1994) C172^C178.
[11] S. Gru«nder, A. Thiemann, M. Pusch, T.J. Jentsch, Nature
360 (1992) 759^762.
[12] D. Duan, C. Winter, S. Cowley, J.R. Hume, B. Horwitz,
Nature 390 (1997) 417^421.
[13] M. Paulmichl, Y. Li, K. Wickman, M. Ackerman, E. Per-
alta, D. Clapham, Nature 356 (1992) 238^241.
[14] B. Fie¤vet, N. Gabillat, F. Borgese, R. Motais, EMBO J. 14
(1995) 5158^5169.
[15] R. Dermietzel, T.-K. Hwang, R. Buettner, A. Hofer, E. Dot-
zler, M. Kremer, R. Deutzmann, F.P. Thinnes, G.I. Fish-
man, D.C. Spray, D. Siemen, Proc. Natl. Acad. Sci. USA 91
(1994) 499^503.
[16] J.R. Moorman, S.J. Ackerman, G.C. Kowdley, M.P. Gri⁄n,
J.P. Mounsey, Z. Chen, S.E. Cala, J.J. O’Brian, G. Szybo,
L.R. Jones, Nature 377 (1995) 737^740.
[17] M. Kawasaki, S. Uchida, T. Monkawa, A. Miyawaki, K.
Mikoshiba, F. Marumo, S. Sasaki, Neuron 12 (1994) 597^
604.
[18] C. Lorenz, M. Pusch, T. Jentsch, Proc. Natl. Acad. Sci. USA
93 (1996) 13362^13366.
[19] G.B. Krapvinsky, M.J. Ackerman, E.A. Gordon, L.D.
Krapvinsky, D.E. Clapham, Cell 76 (1994) 439^448.
[20] M. Coca-Prados, J. Sanchez-Torres, K. Peterson-Yantorno,
M.M. Civan, J. Membr. Biol. 150 (1996) 197^208.
[21] W.H. Yu, W. Wolfgang, M. Forte, J. Biol. Chem 270 (1995)
13998^14006.
[22] S. Bro«er, B. Rahman, G. Pellegri, L. Pellerin, J.L. Martin, S.
Verleysdonk, B. Hamprecht, P.J. Magistretti, J. Biol. Chem.
272 (1997) 30096^30102.
[23] S. Chu, C.B. Murray, M.M. Liu, P.L. Zeitlin, Nucleic Acids
Res. 24 (1996) 3453^3457.
[24] E.R. Liman, J. Tytgat, P. Hess, Neuron 9 (1992) 861^871.
[25] S. Bro«er, A. Bro«er, B. Hamprecht, Biochim. Biophys. Acta
1192 (1994) 95^100.
[26] L. Buckingman, J. Duncan, Biochim. Biophys. Acta 729
(1983) 115^122.
[27] K. Steinmeyer, B. Schwappach, M. Bens, A. Vandewalle, T.
Jentsch, J. Biol. Chem. 270 (1995) 31172^31177.
[28] M.W. Musch, E.M. Davis-Amaral, H.H. Vandenburgh, L.
Goldstein, P£ugers Arch. 436 (1998) 415^422.
[29] G. Buyse, T. Voets, J. Tytgat, C. De Greef, G. Droogmanns,
B. Nilius, J. Eggermont, J. Biol. Chem. 272 (1997) 3615^
3621.
[30] M.J. Ackerman, K. Wickman, D.E. Clapham, J. Gen. Phys-
iol. 103 (1994) 153^179.
[31] M. Hand, R. Morrison, K. Strange, J. Membr. Biol. 157
(1997) 9^16.
[32] A. Bro«er, B. Hamprecht, S. Bro«er, Biochem. J. 333 (1998)
549^554.
[33] K. Kirk, J.C. Ellory, J.D. Young, J. Biol. Chem. 267 (1992)
23475^23478.
[34] D.B. Shennan, S.A. McNeillie, D.E. Curran, Exp. Physiol.
79 (1994) 797^808.
BBAMEM 77871 24-7-00
C. Stegen et al. / Biochimica et Biophysica Acta 1467 (2000) 91^100100
